In the latest report by Future Market Insights, the lead research consultant estimates the global Neurovascular Device market value to reach US$ 3.0 billion in 2024.
The upward trajectory will continue securing growth, with projections indicating a market value of US$ 3.9 billion by 2034. This equates to a moderate CAGR of 2.7% through the forecast period.
| Attributes | Key Insights |
|---|---|
| Neurovascular Device Market Estimated Size in 2024 | US$ 3.0 billion |
| Projected Market Value in 2034 | US$ 3.9 billion |
| Value-based CAGR from 2024 to 2034 | 2.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for neurovascular device rose at a 5.1% CAGR between 2019 and 2023. The global market is achieving heights to grow at a moderate CAGR of 2.7% over the forecast period 2024 to 2034. Several advancements were made in the neurovascular equipment category, during the historical period, such as the creation of new stent designs, embolization techniques as well as imaging technologies.
Increasing prevalence of neurovascular diseases including stroke, aneurysms, and AVMs across the globe also contributed to the increasing demand for neurovascular devices. Patients as well as the healthcare providers shifted their preference towards the minimally invasive procedures as compared to traditional surgeries, owing to their low risks implications, shorter recovery periods and better diagnostic advantages.
Healthcare spending is projected is all set to climb up particularly in developing countries in the coming years. The increased investment will augment the demand for neurovascular devices and drive market expansion.
Regulatory reforms aimed at streamlining the approval process for medical devices and ensuring patient safety will facilitate market access for neurovascular device manufacturers.
Faster regulatory approvals and expanded reimbursement coverage will drive market growth and innovation. Advances in genomics, proteomics, as well as imaging technologies will accelerate the adoption of personalized medicine approaches in neurovascular care. Neurovascular devices tailored to individual patient characteristics and disease profiles will become increasingly important, leading to market growth.
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by India and Thailand. The countries will lead the market through 2034.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 1.4% |
| Germany | 2.2% |
| France | 3.3% |
| Thailand | 3.4% |
| India | 5.5% |
The neurovascular device market in the United States will expand at a CAGR of 1.4% through 2034. The country is a hub for medical innovation, with ongoing advancements in neurovascular devices such as stents, embolic coils, thrombectomy devices, and flow diverters.
The technological innovations improve the efficacy, safety, and outcomes of neurovascular interventions, augmenting the market growth. The United States has a significant burden of neurovascular diseases such as stroke, aneurysms, and arteriovenous malformations.
There is a growing demand for neurovascular devices to treat and manage these diseases, with an aging population and changing lifestyles contributing to the rise in these conditions.
The neurovascular device market in the United Kingdom to expand at a CAGR of 2.2% through 2034. Government initiatives aimed at improving stroke care and reducing the burden of neurovascular diseases contribute to market growth.
Funding for stroke prevention programs, research grants, and investments in healthcare infrastructure further bolster the neurovascular device market in the country.
The United Kingdom has a well-developed healthcare infrastructure, including advanced hospitals, specialized neurovascular centers, and skilled healthcare professionals. The infrastructure supports the diagnosis, treatment, and management of neurovascular diseases, creating a conducive environment for market growth.
Neurovascular device trends in France are taking a turn for the better. A 3.3% CAGR is forecast for the country from 2024 to 2034. France has an aging population, which is more susceptible to neurovascular diseases.
The growing elderly population increases the demand for neurovascular interventions and devices to manage conditions such as stroke and cerebral aneurysms.
Public awareness campaigns and educational programs raise awareness about the signs, symptoms, and risk factors associated with neurovascular diseases. Increased awareness leads to earlier diagnosis and treatment, driving the demand for neurovascular devices in France.
The neurovascular device market in Thailand is poised to expand at a CAGR of 3.4% through 2034. Thailand has emerged as a popular destination for medical tourism due to its high quality healthcare services, affordable costs, and well trained medical professionals.
The influx of medical tourists seeking neurovascular treatments creates additional demand for neurovascular devices and procedures, accelerating the market growth. Increasing healthcare expenditure, both public and private in Thailand, reflects the growing investment in healthcare infrastructure, technology, and services.
The higher healthcare spending contributes to the expansion of neurovascular services and the adoption of advanced medical devices, including neurovascular devices.
The neurovascular device market in India will expand at a CAGR of 5.5% through 2034. The expansion of health insurance coverage in India, both through government schemes and private insurance providers, improves access to healthcare services for a larger segment of the population.
The affordability of neurovascular treatments increases, with more people covered by health insurance, stimulating market growth for neurovascular devices. India is increasingly becoming a hub for medical research and innovation, with the government and private sector investing in research and development initiatives.
The development of indigenous neurovascular devices, as well as collaborative research projects with international partners, leads to the introduction of innovative products tailored to the Indian market, stimulating market growth.
The below table highlights how aneurysm coiling and embolization segment is leading the market in terms of product type, and will account for a share of 31.7% in 2024.
Based on disease pathology, the cerebral aneuryms segment is gaining heights and will to account for a share of 26.9% in 2024.
| Category | Shares in 2024 |
|---|---|
| Aneurysm Coiling and Embolization | 31.7% |
| Cerebral Aneuryms | 26.9% |
Based on product type, the aneurysm coiling and embolization segment will dominate the neurovascular device market. Aneurysms, particularly intracranial aneurysms, are a significant health concern globally.
The growing incidence of aneurysms, coupled with advancements in imaging technologies leading to better detection rates, is propelling the demand for aneurysm coiling and embolization devices. Aneurysm coiling and embolization procedures offer minimally invasive alternatives to traditional surgical treatments for aneurysms.
Patients and healthcare providers increasingly prefer these less invasive procedures due to their lower risk of complications, shorter recovery times, and better outcomes, thus boosting the demand for related devices.
In terms of disease pathology, the cerebral aneuryms segment will dominate the neurovascular device market. Technological advancements in aneurysm coiling and embolization devices have significantly improved treatment outcomes for cerebral aneurysms.
Innovations such as detachable coils, flow diverters, and intrasaccular devices offer more effective and minimally invasive options for managing cerebral aneurysms, thereby driving segmental growth.
Cerebral aneurysms are a common and serious neurovascular condition, with a significant proportion of cases leading to potentially life threatening complications such as subarachnoid hemorrhage. The increasing incidence of cerebral aneurysms globally is a primary driver for the growth of this segment.
The neurovascular device market is characterized by intense competition among key players striving to maintain or enhance their market share through strategic initiatives, product innovation, and differentiation strategies.
Company Portfolio
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 3.0 billion |
| Projected Market Valuation in 2034 | US$ 3.9 billion |
| Value-based CAGR 2024 to 2034 | 2.7% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ Billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The neurovascular device market is projected to reach a valuation of US$ 3.0 billion in 2024.
The neurovascular device industry is set to expand by a CAGR of 2.7% through 2034.
The neurovascular device market is forecast to reach US$ 3.9 billion by 2034.
India is set to be the top performing market, exhibiting a CAGR of 5.5% through 2034.
Aneurysm coiling and embolization devices segment is preferred, and will hold the major share of 33.2% through 2024.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Manufacturer
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Device
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Device, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Device, 2024 to 2034
5.3.1. Cerebral Embolization and Aneurysm Coiling Devices
5.3.1.1. Embolic Coils
5.3.1.2. Flow Diversion Devices
5.3.1.3. Liquid Embolic Agents
5.3.2. Cerebral Angioplasty and Stenting Systems
5.3.2.1. Carotid Artery Stents
5.3.2.2. Embolic Protection
5.3.3. Neurothrombectomy Devices
5.3.3.1. Clot Retrieval Devices
5.3.3.2. Suction Devices/Aspiration Catheters
5.3.3.3. Vascular Snares
5.3.4. Support Devices
5.3.4.1. Micro Catheters
5.3.4.2. Micro Guidewires
5.3.5. Trans Radial Access Devices
5.4. Y-o-Y Growth Trend Analysis By Device, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Device, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Disease Pathology
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Disease Pathology, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Disease Pathology, 2024 to 2034
6.3.1. Ischemic Strokes
6.3.2. Cerebral Aneurysm
6.3.3. Carotid Artery Stenosis
6.3.4. Arteriovenous Malformations
6.3.5. Fistulas
6.3.6. Others
6.4. Y-o-Y Growth Trend Analysis By Disease Pathology, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Disease Pathology, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2024 to 2034
7.3.1. Hospitals & Surgical Centres
7.3.2. Ambulatory Care Centres
7.3.3. Research Laboratories
7.3.4. Academic Institutes
7.4. Y-o-Y Growth Trend Analysis By End-User, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By End-User, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Device
9.2.3. By Disease Pathology
9.2.4. By End-User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Device
9.3.3. By Disease Pathology
9.3.4. By End-User
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Device
10.2.3. By Disease Pathology
10.2.4. By End-User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Device
10.3.3. By Disease Pathology
10.3.4. By End-User
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Device
11.2.3. By Disease Pathology
11.2.4. By End-User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Device
11.3.3. By Disease Pathology
11.3.4. By End-User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Device
12.2.3. By Disease Pathology
12.2.4. By End-User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Device
12.3.3. By Disease Pathology
12.3.4. By End-User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Device
13.2.3. By Disease Pathology
13.2.4. By End-User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Device
13.3.3. By Disease Pathology
13.3.4. By End-User
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Device
14.2.3. By Disease Pathology
14.2.4. By End-User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Device
14.3.3. By Disease Pathology
14.3.4. By End-User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Device
15.2.3. By Disease Pathology
15.2.4. By End-User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Device
15.3.3. By Disease Pathology
15.3.4. By End-User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Device
16.1.2.2. By Disease Pathology
16.1.2.3. By End-User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Device
16.2.2.2. By Disease Pathology
16.2.2.3. By End-User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Device
16.3.2.2. By Disease Pathology
16.3.2.3. By End-User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Device
16.4.2.2. By Disease Pathology
16.4.2.3. By End-User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Device
16.5.2.2. By Disease Pathology
16.5.2.3. By End-User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Device
16.6.2.2. By Disease Pathology
16.6.2.3. By End-User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Device
16.7.2.2. By Disease Pathology
16.7.2.3. By End-User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Device
16.8.2.2. By Disease Pathology
16.8.2.3. By End-User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Device
16.9.2.2. By Disease Pathology
16.9.2.3. By End-User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Device
16.10.2.2. By Disease Pathology
16.10.2.3. By End-User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Device
16.11.2.2. By Disease Pathology
16.11.2.3. By End-User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Device
16.12.2.2. By Disease Pathology
16.12.2.3. By End-User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Device
16.13.2.2. By Disease Pathology
16.13.2.3. By End-User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Device
16.14.2.2. By Disease Pathology
16.14.2.3. By End-User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Device
16.15.2.2. By Disease Pathology
16.15.2.3. By End-User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Device
16.16.2.2. By Disease Pathology
16.16.2.3. By End-User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Device
16.17.2.2. By Disease Pathology
16.17.2.3. By End-User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Device
16.18.2.2. By Disease Pathology
16.18.2.3. By End-User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Device
16.19.2.2. By Disease Pathology
16.19.2.3. By End-User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Device
16.20.2.2. By Disease Pathology
16.20.2.3. By End-User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Device
16.21.2.2. By Disease Pathology
16.21.2.3. By End-User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Device
16.22.2.2. By Disease Pathology
16.22.2.3. By End-User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Device
16.23.2.2. By Disease Pathology
16.23.2.3. By End-User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Device
17.3.3. By Disease Pathology
17.3.4. By End-User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Medtronic
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. Penumbra, Inc.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Stryker
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Johnson and Johnson Services, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. MicroPort Scientific Corporation
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Acandis GmbH
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. MicroVention, Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. NeuroVasc Technologies, Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. Asahi Intecc USA, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Perflow Medical Ltd.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Neurovascular Device Market
